Number of expensive cancer drugs no longer reimbursed by health insurer, patients and oncologists are not happy

A number of expensive cancer drugs will no longer be reimbursed by health insurers from Wednesday. The Healthcare Institute says that. New research shows that treatment with so-called PARP inhibitors for people with ovarian cancer and metastatic breast cancer does not always lead to a longer life.

ttn-2